AIDS.GOV | SERVICE LOCATOR | SEARCH

BLOG.AIDS.GOV

MENU

NIH

Starting antiretroviral treatment early improves outcomes for HIV-infected individuals

nih logo

For Immediate Release: Wednesday, May 27, 2015 NIH-funded trial results likely will impact global treatment guidelines A major international randomized clinical trial has found that HIV-infected individuals have a considerably lower risk of developing AIDS or other serious illnesses if they start taking antiretroviral drugs sooner, when their CD4+ T-cell count—a key measure of immune…

BULLETIN: HIV Vaccine Awareness Day 2015

nih logo

May 18, 2015 Vaccination has historically been the best method for protecting against and ultimately defeating mankind’s most devastating infectious diseases. Although the path to developing a safe and effective HIV vaccine has so far been difficult, achieving this goal remains key to realizing a durable end to the global HIV/AIDS pandemic. HIV vaccine development…

New! NIH Clinical Trials Media Player Now Available

NIH media player

Clinical Trials Clinical trials play an immensely important role in finding medical advancements and developing treatments for many diseases and conditions, including HIV. The goal of clinical trials is to determine if a new test or treatment works and is safe. Clinical trials can also look at other aspects of care, such as improving quality…

New NIH Study to Tackle Cardiovascular Heart Disease in HIV-infected Individuals

REPRIEVE trial logo

If you are HIV positive and on antiretroviral therapy (ART), are you doing all you can to maintain and improve your health?  While early diagnosis of HIV infection and use of combination ART has significantly reduced AIDS-related mortality and morbidity in the U.S., it does not completely return you to your pre-infection health status. For…

NIH launches largest clinical trial focused on HIV-related cardiovascular disease

nhlbi logo

Researchers have begun enrolling participants in a multicenter international clinical trial to test whether statin administration can reduce the risk for major adverse cardiovascular events, such as heart attacks, strokes, and heart disease, in people with HIV infection. The trial is supported by the National Institutes of Health’s National Heart, Lung, and Blood Institute (NHLBI)…

Whitescarver steps down as director of NIH’s Office of AIDS Research

nih logo

Jack Whitescarver, Ph.D., who has led the Office of AIDS Research (OAR) at the National Institutes of Health since 2000, announced that he will step down from his post, effective July 1, 2015.  He also serves as NIH Associate Director for AIDS Research. The NIH will appoint an acting director for the office while it…

NIH, South African Medical Research Council award $8 million in HIV, TB grants

nih logo

The National Institutes of Health and the South African Medical Research Council (SAMRC) are awarding 31 grants to U.S. and South African scientists to support research targeting HIV/AIDS, tuberculosis and HIV-related co-morbidities and cancers. The awards, which total $8 million in first-year funding, are the first to be issued through the South Africa–U.S. Program for…

CROI 2015 Highlights: NIH’s Dr. Peter Kim Discusses Tuberculosis

croi2015_w280x100

Tuberculosis (TB) was among the several infectious diseases in addition to HIV that were important topics of discussion during the 2015 Conference on Retroviruses and Opportunistic Infections (CROI)  held in Seattle at the end of last month.  As the conference came to a close, we visited with Dr. Peter Kim about TB, his area of research at…